Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesInternational Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Pharmacological Reviews, 06/24/09
Ye RD et al. - This article aims to provide an overview of the discovery and pharmacological characterization of FPRs, to introduce an International Union of Basic and Clinical Pharmacology (IUPHAR)-recommended nomenclature, and to discuss unmet challenges, including the mechanisms used by these receptors to bind diverse ligands and mediate different biological functions.
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
No evidence for functional selectivity of proxyfan at the human histamine H3-receptor coupled to defined Gi/Go protein heterotrimers
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Metabolic Fate of Lactoferricin Based Antimicrobial Peptides: Effect of Truncation and Incorporation of Amino Acid Analogs on the in vitro Metabolic Stability
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
In vitro Growth Inhibitory Activity and Malaria Risk in a Cohort Study in Mali
Infection and Immunity, 12/02/09
A Multicenter, Double-Blind, Randomized, Parallel Group Study Comparing Polyvinyl Chloride and Polyvinyl Chloride-Free Catheter Materials
The Journal of Urology, 11/24/09
Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study
Anticancer Research, 11/16/09
Sponsor
Article Search
Sponsor